{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/antiplatelet-treatment/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"9532ea0d-f7f7-5a08-9076-dedbf78ca97d","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field a1ff7cb7-dd04-403d-9e15-dad06e5186c4 --><h2>Update</h2><!-- end field a1ff7cb7-dd04-403d-9e15-dad06e5186c4 -->","summary":null,"htmlStringContent":"<!-- begin item 8bb86958-d078-4c0f-8fa8-c551310f7ff4 --><!-- end item 8bb86958-d078-4c0f-8fa8-c551310f7ff4 -->","topic":{"id":"86dfa76b-bc1a-5d4b-bf7c-018d5d031947","topicId":"a68e1521-d84e-4abb-bb17-6186ba7a891a","topicName":"Antiplatelet treatment","slug":"antiplatelet-treatment","lastRevised":"Last revised in August 2020","chapters":[{"id":"af85e41e-4007-5daa-bc95-35aa03621ea0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"db8ef934-0123-530e-9f34-52d23ea99e56","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ebaf9360-bb92-51bc-8aba-ac3293fa1416","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b34f13e6-85f8-5c85-b2f7-5678c0779a07","slug":"changes","fullItemName":"Changes"},{"id":"9532ea0d-f7f7-5a08-9076-dedbf78ca97d","slug":"update","fullItemName":"Update"}]},{"id":"0370616e-85d0-5654-b5ad-ea9980ad8eaa","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"24bebba9-1157-505c-834d-bf255dd856a9","slug":"goals","fullItemName":"Goals"},{"id":"b1ab86f3-b045-5a24-b8ea-506ae6fa94c8","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cb61b0c8-a7f6-5e31-af33-9c4ade31a493","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"19dcf0a2-d60c-5fe4-94b7-d902d7cc17f8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"758947ec-f9bc-59c9-a07f-663f738f5428","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8c16356c-f5cf-54fc-99e8-ccc08af83ec7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"30e0cacd-1816-520e-8f4a-aba760ce71f5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9e23a119-ae6d-5e11-9691-ed23c4016c39","slug":"definition","fullItemName":"Definition"},{"id":"2ef5b7fd-3211-5769-8a72-083d9f8c40c8","slug":"mechanism-of-action","fullItemName":"Mechanism of action"},{"id":"ef9f4561-2787-59c9-974b-b656929c553c","slug":"indications","fullItemName":"Indications"},{"id":"7692771a-8763-57f6-b4fe-d4711f820cfb","slug":"complications","fullItemName":"Complications"}]},{"id":"d31d1a85-d8c2-5598-b7e0-e8b2da36e45c","fullItemName":"Management","slug":"management","subChapters":[{"id":"81844a0f-b280-563a-b66c-4a5dba6e1e9c","slug":"primary-prevention-of-cvd","fullItemName":"Scenario: Primary prevention of CVD"},{"id":"c2fb4ffa-788d-5d77-a694-3e30c3008d35","slug":"secondary-prevention-of-cvd","fullItemName":"Scenario: Secondary prevention of CVD"}]},{"id":"85828cd6-6943-58a7-9657-71760be76497","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d408bf47-147e-5914-ab35-c4142ec2a33e","slug":"low-dose-aspirin","fullItemName":"Low dose aspirin"},{"id":"4098d4bf-7db2-5e79-bdec-17a2bbfaca6a","slug":"clopidogrel","fullItemName":"Clopidogrel"},{"id":"d5d8e5ca-9f57-5ac9-955b-614b85700f3e","slug":"dipyridamole","fullItemName":"Dipyridamole"},{"id":"52159350-4f8e-536b-99c4-a75908d6233a","slug":"prasugrel","fullItemName":"Prasugrel"},{"id":"92100407-8f08-53c0-8df1-1e802f4dcbe9","slug":"ticagrelor","fullItemName":"Ticagrelor"}]},{"id":"ec007ae2-2b14-50b1-a091-3875c81c5adb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f54cfffb-be9e-5523-a47f-c1100845c9c4","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4ce7f1c7-df35-54c7-9f8b-b1aefe5762f1","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f4d603b9-b19a-53ac-8058-8c414be0a10b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"69fb4d5c-2946-5ef6-8c7f-b5f81dd52f9c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d1e16069-862f-500a-9f58-e84cb201da64","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"fab694fa-9176-5402-b7b5-729a22dd611f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3852e22b-c968-5afe-81be-ac1efce390da","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ebaf9360-bb92-51bc-8aba-ac3293fa1416","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"6cfb621d-8aa0-5efd-b6a7-a48c52ef0096","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 935a4f95-568f-4ed2-a2fa-2f411be44228 --><h3>New evidence</h3><!-- end field 935a4f95-568f-4ed2-a2fa-2f411be44228 -->","summary":null,"htmlStringContent":"<!-- begin item c274b307-81fb-4cc7-b02c-dab599ad3259 --><!-- begin field 688470fc-bcee-4d77-a668-d6b8e12df8e7 --><h3>Evidence-based guidelines</h3><!-- end field 688470fc-bcee-4d77-a668-d6b8e12df8e7 --><!-- begin field bcaf2e93-b02a-409a-8a14-04cb1be264ec --><p>No new evidence-based guidelines since 1 June 2018.</p><!-- end field bcaf2e93-b02a-409a-8a14-04cb1be264ec --><!-- begin field 41264edc-ae1a-45fd-bf36-31830101e813 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 41264edc-ae1a-45fd-bf36-31830101e813 --><!-- begin field e1d529da-c435-41b5-b148-18ddc838272f --><p>No new HTAs since 1 June 2018.</p><!-- end field e1d529da-c435-41b5-b148-18ddc838272f --><!-- begin field bc2569c6-58b7-458a-8673-cfc94d316688 --><h3>Economic Appraisals</h3><!-- end field bc2569c6-58b7-458a-8673-cfc94d316688 --><!-- begin field 096e2c63-40d0-4198-8ce3-5a8d05e45c62 --><p>No new economic appraisals relevant to England since 1 June 2018.</p><!-- end field 096e2c63-40d0-4198-8ce3-5a8d05e45c62 --><!-- begin field 372228b0-a180-4180-85cd-2e0881417aa1 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 372228b0-a180-4180-85cd-2e0881417aa1 --><!-- begin field 3cae4971-fe6c-4ea8-82ac-3c032e27fc4d --><p>No new systematic reviews published since 1 June 2018.</p><!-- end field 3cae4971-fe6c-4ea8-82ac-3c032e27fc4d --><!-- begin field ec7e7065-acfb-45de-86d9-a8a3fe7a3c0e --><h3>Primary evidence</h3><!-- end field ec7e7065-acfb-45de-86d9-a8a3fe7a3c0e --><!-- begin field 46813346-540e-4df2-8dce-208f3fce9101 --><ul><li>Szummer, K., Montez-Rath, M.E., Alfredsson, J., et al. (2020) <em>Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the SWEDEHEART registry</em>. Circulation. [<a href=\"https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050645\" data-hyperlink-id=\"63143cf7-f72c-4b11-8ea0-ac2c00b58683\">Abstract</a>]</li></ul><!-- end field 46813346-540e-4df2-8dce-208f3fce9101 --><!-- end item c274b307-81fb-4cc7-b02c-dab599ad3259 -->","subChapters":[]},{"id":"ba41f9ac-2d74-51dc-ad06-2df4f5e5296e","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 9737b8e9-0e34-4944-890a-d682f2d0e02a --><h3>New policies</h3><!-- end field 9737b8e9-0e34-4944-890a-d682f2d0e02a -->","summary":null,"htmlStringContent":"<!-- begin item 0607195c-ba16-45b2-b668-eb5d93c6ee42 --><!-- begin field 86b7f588-2cd8-4b2c-9008-37eab8acc823 --><p>No new national policies or guidelines since 1 June 2018.</p><!-- end field 86b7f588-2cd8-4b2c-9008-37eab8acc823 --><!-- end item 0607195c-ba16-45b2-b668-eb5d93c6ee42 -->","subChapters":[]},{"id":"5e3ba6e9-54c7-581a-a24f-d6a4fb491f3d","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field ae3dc649-c4db-4cd8-91a5-0a6dea7cc757 --><h3>New safety alerts</h3><!-- end field ae3dc649-c4db-4cd8-91a5-0a6dea7cc757 -->","summary":null,"htmlStringContent":"<!-- begin item 2338118f-8654-4957-b34b-c9f34e7495d6 --><!-- begin field 83be47a9-4590-4bd6-9a57-6f7f25c2256c --><p>No new safety alerts since 1 June 2018.</p><!-- end field 83be47a9-4590-4bd6-9a57-6f7f25c2256c --><!-- end item 2338118f-8654-4957-b34b-c9f34e7495d6 -->","subChapters":[]},{"id":"8e4c6631-f4f0-52b2-af2d-79895f0cbcab","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 9810cbef-4c3b-49f5-995f-50dc764121be --><h3>Changes in product availability</h3><!-- end field 9810cbef-4c3b-49f5-995f-50dc764121be -->","summary":null,"htmlStringContent":"<!-- begin item 5e4aea88-788b-4e16-929d-4fb4e245dc34 --><!-- begin field 8b73c7d4-79b8-4131-b396-10c2f88d7637 --><p>No changes in product availability since 1 June 2018.</p><!-- end field 8b73c7d4-79b8-4131-b396-10c2f88d7637 --><!-- end item 5e4aea88-788b-4e16-929d-4fb4e245dc34 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}